Codexis, Inc. (CDXS) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 Redwood City, CA, 美国. 现任CEO为 Alison Moore.
CDXS 拥有 IPO日期为 2010-04-22, 188 名全职员工, 在 NASDAQ Global Select, 市值为 $215.36M.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
